findmyKOL

Sirisha Yarlagadda, MD

Basic profile

Memorial Hospital

ORCIDNone on fileNPI
RegionColorado Springs, CO · WestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Sirisha Yarlagadda is a Cardiology physician affiliated with Memorial Hospital. OpenAlex indexes 11 publications with 352 citations (h-index 4).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
11publications

Distinct works indexed by OpenAlex.

352citations

Total citations across indexed works.

4h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1400 E Boulder St Ste 700
Colorado Springs, CO 809095533

Telephone

719-635-7172

Registry record last updated 21 Jul 2022.

View the NPPES registry record

Industry payments

4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    86.2%
    Statin20%
    Atorvastatin Calcium49%Rosuvastatin Calcium44%Pravastatin Sodium5%Simvastatin2%
    Part D<11 patients
    Beta blocker19.6%
    Metoprolol Succinate51%Carvedilol19%Metoprolol Tartrate13%Bisoprolol Fumarate9%Atenolol3%Nebivolol Hcl2%Sotalol2%Propranolol Hcl Er1%
    Part D<11 patients

    + 18 more classes in this area

  • Blood & clotting

    8.9%
    Factor Xa inhibitor5.9%
    Eliquis84%Xarelto16%
    Part D70 patients
    P2Y12 inhibitor1.7%
    Clopidogrel100%
    Part D37 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    4.2%
    Potassium supplement2.3%
    Potassium Chloride100%
    Part D43 patients
    SGLT2 inhibitor1.9%
    Farxiga58%Jardiance42%
    Part D20 patients
Where care is delivered (Part B)21.5% facility · 78.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”